| Cat.No. | Name | Information |
|---|---|---|
| M5986 | Suramin sodium salt | Suramin Sodium Salt (Suramin hexasodium salt) is a reversible inhibitor of competitive protein tyrosine phosphatases (PTPases). |
| M10064 | Uridine 5'-diphosphoglucose disodium salt | Uridine 5'-diphosphoglucose disodium salt is an agonist of the P2Y14 receptor, with EC50 of 0.35 μM. Uridine 5′-diphosphoglucose disodium salt (UDP-Glucose sodium salt) can also bind to and activate GPR17, inducing oligodendrocyte differentiation at a maximal concentration of 100 μM. |
| M3069 | Ticagrelor | Ticagrelor is the first reversibly binding oral P2Y12 receptor antagonist with Ki of 2 nM respectively. |
| M2234 | Prasugrel | Prasugrel is a platelet inhibitor irreversibly binding to P2Y12 receptors. |
| M3280 | Clopidogrel | Clopidogrel is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. |
| M10485 | Oleoyl-L-α-lysophosphatidic acid sodium salt | Oleoyl-L-α-lysophosphatidic acid (LPA) sodium salt is a ligand for P2Y5. |
| M10442 | Minodronic acid | Minodronic acid (YM-529) is an antagonist of purinergic P2X2/3 receptors, Minodronic acid (YM-529) is also a third-generation bisphosphonate that directly and indirectly prevents proliferation, induces apoptosis, and inhibits metastasis of various types of cancer cells. |
| M9819 | BAY-1797 | BAY-1797 is a potent and selective, orally active P2X4 antagonist, with IC50 value of 211 nM for human P2X4. |
| M9740 | Aurintricarboxylic acid | Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50 values of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively. |
| M9182 | Gefapixant | Gefapixant, also known as AF-219 or MK-7264, is a P2X3 receptor antagonist. |
| M8762 | Cangrelor tetrasodium | Cangrelor tetrasodium is an adenosine triphosphate analog as well as a potent and selective platelet P2Y12 antagonist and a non-specific GPR17 antagonist. |
| M7668 | BMS-646786 | BMS-646786 is a potent and specific inhibitor of P2Y1 purinergic receptor that inhibits ADP-mediated platelet aggregation in human blood samples. |
| M7452 | UDP disodium salt | UDP disodium salt is a endogenous ligand; competitive antagonist at P2Y 14 receptors. |
| M6848 | JNJ-47965567 | JNJ-47965567 is a potent and selective P2X7 antagonist; brain penetrant. |
| M6480 | AZD 1283 | AZD 1283 is a high affinity P2Y 12 antagonist. |
| M6457 | AR-C 118925XX | AR-C 118925XX is a selective, competitive P2Y2 receptor antagonist. AR-C 118925XX is inactive against a panel of 37 other receptors at a concentration of 10 μM. AR-C 118925XX inhibits ATP-γS-induced mucin secretion in bronchial epithelial cells (IC50 = 1 μM). AR-C 118925XX inhibits P2Y2 receptor-induced β-arrestin translocation in vitro (pA2 = 37.2-51.3 nM). |
| M6374 | A-804598 | A-804598 is a CNS penetrant, competitive and selective P2X7 receptor antagonist with IC50s of 9 nM, 10 nM and 11 nM for mouse, rat and human P2X7 receptors, respectively. |
| M6371 | A-740003 | A-740003 is a potent and selective P2X7 antagonist. |
| M6351 | 5-OMe-UDP trisodium salt | 5-OMe-UDP trisodium salt is a potent P2Y 6 agonist. |
| M6347 | 5-BDBD | 5-BDBD is a potent P2X4 receptor antagonist. |
| M5023 | Clopidogrel hydrogen sulfate | S-(+)-Clopidogrel Hydrogen Sulfate is the S enantiomer of clopidogrel and a P2Y12 receptor inhibitor. |
| M3949 | AF 353 | AF-353 is a novel, potent and orally bioavailable P2X3 receptor antagonist, with a pIC50 of 8.0 for both human and rat P2X3, and with a pIC50 of 7.3 for human P2X2/3. |
| M3233 | GW791343 trihydrochloride | GW791343 trihydrochloride is ahydrochloride salt form of GW791343, which is a non-competitive allosteric modulator of human P2X7 receptor inhibitor with pIC50 of 7. |
| M2954 | PPADS Tetrasodium | PPADS tetrasodium salt is a non-selective P2 purinergic antagonist blocking recombinant P2X1, P2X2, P2X3, P2X5 with IC50 of 1-2.6 μM, native P2Y2-like with IC50 of ~ 0.9 mM, and recombinant P2Y4 receptors with IC50 of ~ 15 mM |
| M2869 | MRS 2578 | MRS2578 is a potent P2Y6 receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
